Patent · US Active

Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof

US8715728B2 · kind B2 · utility

0Cited by

50References

16Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thomas Friedl · Seekirchen am Wallersee, AT
Rolf-Stefan Brickl

Key dates

Filing date	Dec 3, 2009
Grant date	May 6, 2014
Priority date	—
Expiry date	Oct 22, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An extended release pellet comprising an active ingredient selected from pramipexole and the pharmaceutically acceptable salts thereof, and at least one release-modifying excipient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.